ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Internal Medicine

Top Internal Medicine Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NEAL SORENSEN MD

Internal Medicine

16,561

$843K

754
685 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $54

THOMAS ADDISON MD

Internal Medicine

15,223

$795K

566
479 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

STEVEN CHRZANOWSKI MD

Internal Medicine

15,213

$792K

608
514 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

JACOB TAVERNA MD

Internal Medicine

14,309

$767K

499
442 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $54

PETER SZEKELY MD

Internal Medicine

14,243

$686K

734
631 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $54

LUCINDA HUSBY MD

Internal Medicine

13,872

$596K

559
525 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $54

KARI KALE MD

Internal Medicine

13,553

$695K

661
561 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $54

J CALDWELL MD

Internal Medicine

12,908

$546K

639
561 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $54

FREDERICK MILLER DO

Internal Medicine

12,549

$651K

460
391 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

KATHLEEN KELLOGG MD

Internal Medicine

12,349

$702K

432
354 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $54

DOUGLAS WADLE MD

Internal Medicine

12,210

$584K

451
380 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $54

EDWARD MALTERS MD

Internal Medicine

12,194

$770K

563
490 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $54

DIANE YAHN MD

Internal Medicine

12,076

$556K

714
622 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $54

STEVEN GERSTNER MD

Internal Medicine

12,060

$595K

615
557 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $54

RAJOHN KARANJAI M,D.

Internal Medicine

12,008

$747K

491
429 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $54

BRADFORD BERGMAN MD

Internal Medicine

11,423

$578K

461
406 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $54

STEPHEN BASE MD

Internal Medicine

11,301

$575K

339
296 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $54

TONY LENZ MD

Internal Medicine

11,001

$462K

510
456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $54

JONATHAN BODINE D.O.

Internal Medicine

10,562

$537K

399
352 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $54

KAREN CABELL DO

Internal Medicine

10,516

$660K

427
356 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $54

EDWARD PIERCE MD PC

Internal Medicine

10,487

$747K

302
278 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$71
Average prescription price

Avg: $54

JEFFREY JOHNSON MD

Internal Medicine

10,402

$639K

512
447 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $54

TED SCOFIELD MD

Internal Medicine

9,878

$575K

412
358 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $54

CHARLES MCCLAVE MD

Internal Medicine

9,815

$633K

432
367 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $54

KEVIN SHEEHAN MD

Internal Medicine

9,791

$507K

565
484 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank